SpeedGelRx

MDose v Tube Study

MDose™ Technology Background It has been shown that convenience, ease of dispensing and favorable tolerability are key characteristics that may increase patient compliance with topical dermatologic therapy.[1],[2],[3] Additionally, the quantity of drug utilized with...

Medicare (CGDP) Gap Announcement

Gensco Pharma Announces Additions to 2017 CGDP on CMS Gensco products will be available to MEDICARE patients in 2017

Supply Partners

Gensco Pharma is a FDA licensed pharmaceutical manufacturer focusing on the research, development and marketing of transdermal prescription products. As an innovator of pharmaceutical products, Gensco Pharma currently delivers non-narcotic transdermal analgesic gels...

Got Pain?

Transdermal Pharmaceuticals Clinically Proven APPA | September 2016 Chain Drug Review | July 2016 Chain Drugstore Daily | April 2016

Safety and Efficacy of SpeedGel Rx® In the Symptomatic Treatment of Osteoarthritis in the Interphalangeal Joints

A Randomized, Double-Blind, Clinical Study to Evaluate the Safety and Efficacy of SpeedGel Rx® in the Symptomatic Treatment of Osteoarthritis in the Interphalangeal Joints. This study evaluated the efficacy of SpeedGel Rx® for the treatment of Osteoarthritis of the...

MDose v Tube Study

Medicare (CGDP) Gap Announcement

Supply Partners

Got Pain?

Safety and Efficacy of SpeedGel Rx® In the Symptomatic Treatment of Osteoarthritis in the Interphalangeal Joints

LOOKING TO THE FUTURE